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Abstract
Background: There is evidence of a link between schizophrenia and a deficit of working memory, but this has been derived
from tasks not specifically developed to probe working memory per se. Our aim was to investigate whether working memory
deficits may be detected across different paradigms using the self-ordered pointing task (SOPT) and the visual conditional
associative learning task (VCALT) in patients with schizophrenia spectrum disorders and healthy controls. The current literature
suggests deficits in schizophrenia spectrum disorder patients versus healthy controls but these studies frequently involved small
samples, broad diagnostic criteria, inclusion of patients on antipsychotic medications, and were not controlled for symptom
domains, severity of the disorder, etc. To overcome some of these limitations, we investigated the self-monitoring and
conditional associative learning abilities of a numerically representative sample of healthy controls and a group of non-
deteriorated, drug-free patients hospitalized for a schizophrenia spectrum disorder with florid, mainly positive psychotic
symptoms.
Methods: Eighty-five patients with a schizophrenia spectrum disorder (DSM-IV-TR diagnosis of schizophrenia (n = 71) or
schizophreniform disorder (n = 14)) and 80 healthy controls entered the study. The clinical picture was dominated by positive
symptoms. The healthy control group had a negative personal and family history of schizophrenia or mood disorder and satisfied
all the inclusion and exclusion criteria other than variables related to schizophrenia spectrum disorders.
Results: Compared to controls, patients had worse performances on SOPT, VCALT and higher SOPT/VCALT ratios, not
affected by demographic or clinical variables. ROC curves showed that SOPT, VCALT, and SOPT/VCALT ratio had good
accuracy in discriminating patients from controls. The SOPT and VCALT scores were inter-correlated in controls but not in
patients.
Conclusion: The selection of a clinically homogeneous group of patients, controlled for a number of potential confounding
factors, and the high level of significance found in the different analyses confirm the presence of SOPT and VCALT abnormalities
in a large preponderance of patients with schizophrenia spectrum disorder with positive symptoms. SOPT, VCALT, and SOPT/
VCALT ratio showed good accuracy in discriminating patients from healthy controls. These conclusions cannot be extended to
schizophrenia spectrum disorder patients with a different clinical profile from our patient population.
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Background
A number of independent lines of evidence support the
existence of a link between schizophrenia and a deficit of
working memory. Many patients with schizophrenia
share impairment of the processes responsible for the on-
line maintenance of information necessary to select task-
appropriate action [1,2]. Furthermore, working memory
participates in many domains of functioning which are
critical in schizophrenia [3,4]. The study of working mem-
ory is a valuable tool to investigate the prefrontal cortex
[5], a brain region central to many leading hypotheses of
schizophrenia [6].
Because most of the available evidence is derived from
tasks not specifically developed to probe working mem-
ory per se, we wanted to investigate whether working
memory deficits may be detected across different para-
digms [1]. Within this perspective, a deeper understand-
ing of the performance of schizophrenia patients on the
self-ordered pointing task (SOPT) [7-9] and the visual
conditional associative learning task (VCALT) [9-12]
seems appropriate, given that these two tasks have been
less extensively studied than others.
The SOPT, originally devised by Petrides and Milner [7],
assesses the capacity to initiate and execute a sequence of
responses with self-monitoring of performance and
makes considerable demands on working memory as sub-
jects must constantly compare responses already made
with those remaining. Self-monitoring is considered an
important aspect of executive function [13]. The VCALT
[9,10] is based on the ability to learn associations between
a set of stimuli and a set of responses; these fixed associa-
tions are acquired through a process of "trial and error
learning", consisting of the ability to discriminate
between past correct and incorrect responses and using
this information to guide response selection. Some PET
evidence suggests that the mid-dorsolateral frontal cortex,
which comprises cytoarchitectonic Brodmann areas 46
and 9, may be associated with the performance of non-
spatial self-ordered pointing tasks, while the adjacent area
8 of the posterior-dorsolateral frontal cortex may be acti-
vated during conditional associative learning tasks [9,14].
The current literature on SOPT [15-17] and VCALT [18-
20] consistently supports the presence of deficits in schiz-
ophrenia patients versus healthy controls. However, these
studies frequently involved small samples, utilized broad
diagnostic criteria, included patients taking antipsychotic
medications, and did not control for symptom domains,
severity of the disorder and other putative sources of vari-
ation.
In an attempt to overcome some of these limitations, we
investigated the self-monitoring and the conditional asso-
ciative learning abilities of a numerically representative
sample consisting of healthy controls and a group of non-
deteriorated, drug-free patients hospitalized for a schizo-
phrenia spectrum disorder with florid, mainly positive
psychotic symptoms.
Methods
Subjects
All consenting males and females consecutively and vol-
untarily admitted over a 2-year period to the Brescia Uni-
versity and Spedali Civili Psychiatric Service were
included, provided that they fulfilled predefined inclu-
sion and exclusion criteria at the screening visit.
Inclusion criteria were a DSM-IV-TR diagnosis of schizo-
phrenia, paranoid type, or of schizophreniform disorder
[21] with prevalent delusional and/or hallucinatory
symptoms, a minimum total score of 80 on the Positive
and Negative Syndrome Scale (PANSS) [22], a score of 4
or more on at least two items of the PANSS positive sub-
scale, a minimum antipsychotic drug-free interval of 4
weeks for oral formulations and 6 weeks for depot formu-
lations, a Mini Mental State Examination (MMSE) [23]
score higher than 24, a total intelligence quotient (IQ)
score on the Wechsler Adult Intelligence Scale-Revised
(WAIS-R) [24] higher than 75, and a level of understand-
ing, cooperativeness and attention sufficient enough to
perform neuropsychological tests and give informed con-
sent after a detailed explanation of the procedures and the
nature of the study. Exclusion criteria were older than 75
years, current diagnoses of DSM-IV-TR axis 1 or 2 co-mor-
bid disorders, a history of substance-related disorders in
the preceding 6 months, evidence of head trauma or sei-
zures at any time during the lifespan, concomitant medi-
cal or neurological disorders presumptively able to affect
the neuropsychological performance, and positive quali-
tative assays for alcohol and/or substance of abuse. Oper-
atively, all participants underwent detailed clinical
interviews implemented, when required, by a DSM-IV-TR
adjusted version of the Structured Clinical Interview for
DSM-IV Axis 1 Disorders, Clinician Version (SCID-CV)
[25]. Predominance of positives symptoms was defined as
a PANSS positive/negative subscale score ratio >1. The
PANSS, the MMSE, and the WAIS-R were administered on
the day following the screening visit and before starting
on antipsychotic medication. Patients were also evaluated
for age at the onset of schizophrenia. To establish this, the
appearance of the first psychotic symptoms represented
the pre-identified cut-off; in order to reach as accurate esti-
mates as possible, direct information from patients was
systematically retrieved along with data obtained from at
least one close relative plus, when possible, previous med-
ical reports.BMC Psychiatry 2008, 8:6 http://www.biomedcentral.com/1471-244X/8/6
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The control group consisted of doctors, nurses, employ-
ees, and attendants of Brescia Spedali Civili, students of
Brescia University, or their relatives. For recruitment, the
controls had to be unrelated to other prospective partici-
pants, be unaware of the nature of the neuropsychological
tasks involved in the study, have a negative personal and
family history of schizophrenia and mood disorders, and
satisfy all the inclusion and exclusion criteria applied to
the patients, with the exception of those schizophrenia-
related variables. All controls underwent detailed clinical
interviews implemented, when required, by the Diagnos-
tic Interview for Genetic Studies [26] for controls. To
exclude a positive family history for psychosis and mood
disorders, the controls and, in cases of doubt, their family
members were interviewed following an ad hoc question-
naire, which incorporated in-depth information on first-
degree relatives and more general data on second-degree
relatives.
Patients and controls were also questioned about their
school education.
A team of qualified psychiatrists were in charge of data
collection, after training and assessment of inter-rater reli-
ability. Reliability was estimated using videotapes played
by actors in which 20 cases with a schizophrenia spectrum
disorder or a mood disorder with psychotic features were
represented (Cohen's Kappa = 0.80, P < 0.001 for schizo-
phrenia diagnosis; Pearson's r = 0.91, P < 0.01 for PANSS
score, Pearson's r = 0.92, P < 0.01 for age at disease onset).
DSM-IV-TR related variables were independently evalu-
ated by two physicians and, in the case of discordance, a
joint revision of the material took place in the presence of
an independent referee who made the final decision after
discussion. Rating scales and the remaining variables were
rated by only one physician, on rotation.
All the procedures used in this study are an integral part of
the routine employed at the Brescia University and Spe-
dali Civili Psychiatric Unit. Therefore patients were
requested to provide only a written informed consent for
the utilization of data for research purposes, after they
received an explanation about the aims of the study and
the lack of economic interest. The invited partecipants had
also an explicit guarantee of anonymity and the impossi-
bility of identification datails as a unique number linked
all the individual data.
Sample key features
The sample consisted of 165 subjects of Italian ancestry:
71 schizophrenia patients, 14 schizophreniform disorder
patients, and 80 healthy volunteers. Patients and controls
did not differ from each other in age (36 ± 12 vs. 34 ± 10
years, t = 0.82, P = 0.411), sex distribution (49/36 vs. 37/
43 male/female ratio, chi squared = 2.1, P = 0.411), and
educational level (10.5 ± 3.9 vs. 10.1 ± 2.5 years of school,
t = 0.22, P = 0.823). Patients and controls were also com-
parable as to the MMSE (29.11 ± 0.93 vs 29.29 ± 0.90, t =
1.27, P = 0.204) and the IQ (93.89 ± 4.95 vs 94.85 ± 4.71,
t = 1.268, P = 0.207) scores.
Patients had a severe disorder (PANSS total score: mean
98, median 98, 95% CI 86–110) and showed wide inter-
individual variability of both age at disease onset (years:
mean 27.4, median 25, 95% CI 20–32) and duration of
the disorder (years: mean 7.99, median 5, 95% CI 2–12).
At the screening visit, 17 and 68 patients were drug-naive
and drug-free, respectively. Among the drug-free patients,
the last prescription involved second-generation antipsy-
chotics in 85% of the cases.
Neuropsychological tests
Once enrolled, patients and controls were assessed with
both the SOPT and the VCALT. The SOPT and the VCALT
do not have a pre-defined time limit; they are completed
in about 7 and 13 min, respectively. To minimize possible
influences on performance played by even subtle differ-
ences in the explanation of the two tasks, SOPT and
VCALT were described using standardized written texts.
The description of the two tests, the control and assistance
during their completion, and the recording of the results
were carried out by one of the psychiatrists responsible for
the recruitment and the collection of all the data.
Briefly, the SOPT is based on four identical series of eight
cards. On each card, the same eight black and white
abstract designs are represented with a different, casual
distribution. After explanation by the examiner on the
type of performance required, the first card is disclosed. At
this point, the candidate is invited to choose one of the
eight designs. Then the second card is presented and the
candidate is requested to select one of the seven remain-
ing, unidentified designs. Thereafter, the candidate is
invited to choose one design among those previously not
selected whenever a new card is shown. The test ends after
the same procedure is repeated for the second, third, and
fourth card series. The SOPT score is given by the number
of wrong answers, that is how many times the candidate
selected, within each card series, a previously identified
design.
The VCALT is based on eight identical series of four cards.
The four cards of a series contain the same four black and
white abstract designs but differ from each other in the
internal distribution of the designs and the presence of a
coloured strip (yellow, blue, green, or red) on the top.
Before starting and after the explanation about how the
test works, the examiner arbitrarily decides to associate
any design with a specific colour. At this point the candi-BMC Psychiatry 2008, 8:6 http://www.biomedcentral.com/1471-244X/8/6
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date, completely unaware of the four pre-established
design-colour associations, uncovers the first card, links
one of the four designs with the colour of the top strip,
and receives from the examiner a communication
whether the choice corresponds to the pre-established
association or not. The same procedure is repeated with
the second, the third, and the fourth card, respectively.
Once the first card series is completed, the search for the
same design-colour associations is renewed for the other
seven card series, the initial choices of the examiner
remaining valid. The final VCALT score is given by the
number of correct answers, that is how many times the
candidate correctly identified the pre-established design-
colour associations.
During the two tests, the examiner registered the correct
and incorrect answers without any comment about the
performance.
In order to obtain some information about the independ-
ence or the interdependence of the two tasks, the SOPT
and VCALT values were also to calculate a supplementary
unitary index, the SOPT/VCALT ratio.
Statistical analyses
Rough data, expressed as means (SD) or median (IQR) if
continuous and as percentages if categorical, were ana-
lysed by the t-test or the chi-squared test. The possible
confounding effects of key baseline characteristics on
SOPT, VCALT and SOPT/VCALT values were studied by
multivariate linear regression analyses. Logistic regression
analyses were utilized to obtain the SOPT, VCALT and
SOPT/VCALT adjusted odds ratios relative to schizophre-
nia spectrum disorder patients with respect to healthy
controls. ROC analyses of the SOPT, VCALT and SOPT/
VCALT values were performed in order to confirm the
ability of the three neuropsychological measures to dis-
criminate patients from controls and to estimate the best
cut-offs, that is the values that minimize the absolute dif-
ference between sensitivity and specificity. The same ROC
cut-offs valid for the VCALT, SOPT, and SOPT/VCALT
ratio were then used to evaluate the positive and negative
likelihood ratios which provide a direct estimate of how
much the three neuropsychological values change the
odds of having a schizophrenia spectrum disorder.
Inter-rater reliability was estimated using Cohen's kappa
or Pearson's r according to the type of variable considered.
All the statistical analyses were performed using the 'R
Language' freeware statistical package [27].
P values <0.05 were considered statistically significant.
Results
Patients differed remarkably from healthy controls in that
they had more SOPT wrong answers, less VCALT right
answers, and higher SOPT/VCALT ratios (Table 1).
Patients with schizophrenia and those with schizophrenia
spectrum disorder did not differ in SOPT, VCALT, and
SOPT/VCALT values although a numerical advantage of
patients with schizophreniform disorder emerged for the
VCALT (Table 2). Furthermore, the SOPT and the VCALT
scores were inter-correlated with each other in healthy
controls but not in schizophrenia spectrum disorder
patients (Fig. 1).
Multivariate linear regression analyses showed that SOPT,
VCALT, and SOPT/VCALT values were not significantly
affected by age, gender, and educational level in both the
patient and the control groups and by duration of the dis-
order, age at the disease onset, and PANSS total score in
the patient group (Table 3).
Logistic regression analyses demonstrated that SOPT,
VCALT, and SOPT/VCALT adjusted for age, gender, and
educational level discriminate schizophrenia spectrum
disorder patients from controls (Table 4).
The ROC analyses confirmed a valuable patient-control
separation as the SOPT, VCALT, and SOPT/VCALT areas
under the curve exceeded 0.5 (Fig. 2), and demonstrated
that a SOPT score >5, a VCALT score <21, and a SOPT/
VCALT ratio >0.24 gave the best discriminatory accuracy
(Fig. 2 and Table 5). Moreover, ROC positive and negative
likelihood ratios for the three neuropsychological meas-
Table 1: Test performance for SOPT, VCALT and SOPT/VCALT ratio of schizophrenia spectrum disorder patients and healthy 
control subjects
Schizophrenia spectrum disorders patients (n = 85) Controls (n = 80) Test statisticsa
Mean (SD) Median 25–75th percentile Mean (SD) Median 25–75th percentile tp
SOPT (wrong answers) 6.8 (2.4) 7.0 5.0–8.0 3.4 (1.6) 3 2.0–4.0 11.74 <0.001
VCALT (right answers) 18.5 (5.7) 18 14.5–23.0 23.5 (4.2) 24.0 21.0–26.0 6.40 <0.001
SOPT/VCALT ratio 0.42 (0.23) 0.364 0.25–0.50 0.15 (0.09) 0.125 0.09–0.20 12.32 <0.001
aWilcoxon test.BMC Psychiatry 2008, 8:6 http://www.biomedcentral.com/1471-244X/8/6
Page 5 of 8
(page number not for citation purposes)
ures indicated numerically lower, though not statistically
significant, odds for a schizophrenia spectrum disorder
utilizing the VCALT rather than the SOPT or the SOPT/
VCALT ratio cut-off (Table 6).
Discussion and conclusion
Three key points best summarize the results of our study.
First, acute patients with a schizophrenia spectrum disor-
der performed worse in SOPT and VCALT and had higher
SOPT/VCALT ratios versus a group of healthy controls
matched for age, sex, and educational level. Second, the
cut-offs derived from the ROC curves showed that SOPT,
VCALT, and SOPT/VCALT ratio had good accuracy in dis-
criminating patients from controls. Third, the SOPT and
the VCALT performances were inter-correlated with each
other in the healthy controls but not in the patient group.
These results are not likely due to chance. Indeed, the sam-
ple of patients and controls was sizeable; the selection cri-
teria limited the recruitment a priori to a rather clinically
homogeneous group of patients, and a discrete number of
possible demographic and clinical confounders had been
statistically controlled. Given that important limitations
inherent in many pre-existing studies on the same tasks
[15-20] have been bypassed, the conclusion that a large
preponderance of intellectually normal, non-deteriorated,
Table 2: SOPT, VCALT and SOPT/VCALT ratio: comparison between schizophrenia and schizophreniform disorder patients
Schizophrenia patients (71) Schizophreniform disorder patients (14) F(1,83) P
Mean ± SD Median 25–75th percentile Mean ± SD Median 25–75th percentile
SOPT 6.8 ± 2.3 7.00 5.0–8.0 7.1 ± 2.6 7.0 5.3–8.8 0.22 0.639
VCALT 17.8 ± 5.5 18 14.0–22.0 21.4 ± 6.5 22.0 16.5–26.3 3.80 0.055
SOPT/VCALT 0.43 ± 0.24 0.37 0.27–0.5 0.37 ± 0.19 0.3 0.25–0.45 1.10 0.292
aWilcoxon test.
Correlations between the performances on SOPT and VCALT in healthy controls and schizophrenia spectrum disorder  patients Figure 1
Correlations between the performances on SOPT and VCALT in healthy controls and schizophrenia spectrum disorder 
patients.
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antipsychotic drug-free schizophrenia spectrum disorder
patients with a florid phase of psychosis dominated by
positive symptoms have evident SOPT and VCALT deficits
seems therefore fully supported.
However, the adoption of stringent criteria for the selec-
tion of the patients is both a strength and a weakness of
the study because it prevents generalization of the results
to schizophrenia spectrum disorder patients with differ-
ent clinical features and/or currently exposed to antipsy-
chotic medications.
Within these definite boundaries, some further comments
can be made. As far as the timing of appearance of SOPT
and VCALT abnormalities is concerned, the lack of any
correlation with the duration of the disorder in a sample
of patients that included a significant minority of subjects
with schizophreniform disorder suggests that the
observed defects are likely to be phenotypic expressions of
underlying processes which have been structured and
operant at least since the beginning of the illness. How-
ever, this conclusion does not exclude the possibility that,
in the long-term, the progress of the psychosis and/or the
inevitable associated pharmacological manipulation
could exert supplementary effects on the two tasks. The
Areas under the ROC curves of SOPT, VCALT and SOPT/ VCALT ratio Figure 2
Areas under the ROC curves of SOPT, VCALT and SOPT/
VCALT ratio.
Table 3: Multivariate linear regression analyses of variables potentially affecting SOPT, VCALT and SOPT/VCALT values in patients 
and healthy controls
SOPT VCALT SOPT/VCALT
Beta SE P Beta SE P Beta SE P
Patients (n = 85)
Intercept 7.7415 1.956 0.0002 16.534 4.798 0.0009 0.54 0.195 0.0071
Age 0.0399 0.087 0.6485 0.107 0.214 0.6167 -0.0000 0.009 0.9982
Gender (f) 1.1765 0.627 0.0644 0.606 1.538 0.6945 0.039 0.062 0.5345
Educational level -0.0443 0.066 0.5042 0.255 0.162 0.1188 -0.0089 0.007 0.1805
Duration of the disorder -0.0282 0.087 0.7471 -0.227 0.214 0.2907 0.0046 0.009 0.5950
Age at onset -0.0694 0.081 0.3952 -0.065 0.199 0.7441 -0.0032 0.008 0.6947
PANSS total -0.0025 0.016 0.8763 -0.013 0.039 0.7395 0.0001 0.002 0.9463
Controls (n = 80)
Intercept 1.6488 0.161 0.0000 4.7161 0.208 0.0000 0.3710 0.052 0.0000
Age 0.0041 0.003 0.1990 -0.003 0.004 0.4390 0.0011 0.001 0.2830
Gender (f) 0.0635 0.072 0.3840 0.0860 0.094 0.3620 0.0043 0.023 0.8540
Educational level -0.0026 0.010 0.8060 0.0173 0.014 0.2110 -0.0032 0.003 0.3530
Case vs control 0.7756 0.0713 0.0000 -0.5809 0.0921 0.0000 0.2479 0.023 0.0000
Table 4: Logistic regression including the performances on 
SOPT, VCALT, age and educational level
Odds-ratioa Lower Upper P
SOPT 39.63 13 120 <0.001
VCALT 0.18 0.09 0.34 <0.001
SOPT/VCALT 35.91 12 108 <0.001
aAdjusted for age, gender and educational level.BMC Psychiatry 2008, 8:6 http://www.biomedcentral.com/1471-244X/8/6
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observed trend for a worse VCALT performance of schizo-
phrenia patients versus those with a schizophreniform
disorder could fit with this last possibility.
The result that SOPT, VCALT, and SOPT/VCALT ratio
abnormalities were frequently but not systematically asso-
ciated in patients with otherwise largely common clinical
features could be compatible with the hypothesis that two
tasks are sustained by only partially coincident mecha-
nisms.
The ROC likelihood ratios suggest more frequent dysfunc-
tion of the SOPT and agree with the proposal [28,29] that
deficits in self-monitoring play a principal role when pos-
itive symptoms dominate the clinical picture.
Since self-monitoring ability and conditional associative
learning also involve the participation of other relevant
cognitive processes such as attention, active memory, and
inhibition, it seems acceptable to place our results within
the general scenario of the "context processing" theory of
cognitive dysfunctions of schizophrenia [30-33]. The
involvement of multiple cognitive processes in the gener-
ation of SOPT and VCALT performance makes the search
for a restricted anatomic specificity of the two tasks overtly
hard and naive, even though neuroimaging [9,34] and
lesion [7,10,12] studies suggest different roles for the
Brodmann areas 46 and 9 and Brodmann area 8 in the
spatial self-ordered pointing tasks and conditional associ-
ative learning, respectively.
The loss of correlation between SOPT and VCALT moving
from healthy controls to patients may infer that a struc-
tural and/or functional disruption of the normally coop-
erative action between the networks involved should also
exist in schizophrenia spectrum disorders. Within this
proposal, a relative redundancy of the impairment of one
network with respect to the other and/or a pathology of
circuits crucial for their connection could be advocated.
While we wait for direct investigations with neuroimaging
techniques and multiple neuropsychological tasks, it is of
interest to remember that functional disconnectivity has
been proposed as crucial in the pathogenesis of schizo-
phrenia [35] and that abnormal cortical functional con-
nectivity has been demonstrated during impaired
working-memory tasks [36-42].
In conclusion, further research seems warranted in order
to firmly establish how much the SOPT and the VCALT
paradigms may represent a valid tool to evaluate working
memory in patients with schizophrenia or related disor-
ders. The issues that merit priority are: whether and to
what degree the individual SOPT, VCALT, and SOPT/
VCALT values are stable over time, are affected by various
treatments with antipsychotics, and are influenced by
symptom clusters outside those of the positive domain.
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Table 6: ROC positive and negative likelihood ratiosa
Positive likelihood Lower 0.95 Upper 0.95 Negative likelihood Lower 0.95 Upper 0.95
SOPT 5.1 3.0 10.3 0.34 0.23 0.47
VCALT 3.6 2.2 6.6 0.49 0.36 0.65
SOPT/VCALT 6.0 3.6 11.4 0.20 0.12 0.32
aThe likelihood ratio incorporates both the sensitivity and specificity of the test and provides a direct estimate of how much a test result will change 
the odds of having a disease.
Table 5: ROC areas under the curves (AUC) and cut-off values
AUC SE z value Lower 0.95 Upper 0.95 Cut-offsa
SOPT 0.89 0.025 15.7 0.84 0.94 5.00
VCALT 0.76 0.038 6.8 0.69 0.83 21.00
SOPT/VCALT 0.90 0.025 16.3 0.85 0.95 0.24
a"Abnormal" performance: SOPT ≥ 5; VCALT ≤ 21; SOPT/VCALT ≥ 0.24.BMC Psychiatry 2008, 8:6 http://www.biomedcentral.com/1471-244X/8/6
Page 8 of 8
(page number not for citation purposes)
References
1. Lee J, Park S: Working memory impairment in schizophrenia:
a meta-analysis.  J Abnorm Psychol 2005, 114:599-611.
2. Barch DM: What can research on schizophrenia tell us about
the cognitive neuroscience of working memory?  Neuroscience
2006, 139:73-84.
3. Goldman-Rakic PS: Working memory dysfunction in schizo-
phrenia.  J Neuropsychiatry 1994, 6:348-357.
4. Weinberger DR, Berman KF: Prefrontal function in schizophre-
nia: confounds and controversies.  Philos Trans R Soc Lond 1996,
351:1495-1503.
5. Keefe RSE: The contribution of neuropsychology to psychia-
try.  Am J Psychiatry 1995, 152:6-15.
6. Honey GD, Fletcher PC: Investigating principles of human brain
function underlying working memory: what insights from
schizophrenia?  Neuroscience 2006, 139:59-71.
7. Petrides M, Milner B: Deficits on subject-ordered tasks after
frontal- and temporal-lobe lesions in man.  Neuropsychologia
1982, 20:249-262.
8. Shimamura A, Jurica P: Memory interference effects and aging:
Findings from a test of frontal lobe function.  Neuropsychology
1994, 8:408-412.
9. Petrides M, Alivisatos B, Evans AC, Meyer E: Dissociation of
human mid-dorsolateral from posterior dorsolateral frontal
cortex in memory processing.  P r o c Na tl  Ac a d S ci  US A  1993,
90:873-877.
10. Petrides M: Deficits on conditional associative-learning after
frontal and temporal lobe lesions in man.  Neuropsychologia
1985, 23:601-614.
11. Petrides M: Nonspatial conditional learning impaired in
patients with unilateral frontal but not unilateral temporal
lobe excisions.  Neuropsychologia 1990, 28:137-149.
12. Petrides M: Visuo-motor conditional associative learning after
frontal and temporal lobe lesions in the human brain.  Neu-
ropsychologia 1997, 35:989-997.
13. Tranel D, Anderson SW, Benton A: Development of the concept
of "executive function" and its relationship to the frontal
lobes.  In Handbook of Neuropsychology Volume 9. Edited by: Boller F,
Grafman J. Amsterdam: Elsevier Science; 1994:125-148. 
14. Petrides M, Pandya DN: Dorsolateral prefrontal cortex: com-
parative cytoarchitectonic analysis in the human and the
macaque brain and corticocortical connection patterns.  Eur
J Neurosci 1999, 11:1011-1036.
15. Ganzevles PG, Hoenen MA: A preliminary study of externally
and self-ordered task performance in schizophrenia.  Schizo-
phr Res 1995, 16:67-71.
16. Stone M, Gabrieli JD, Stebbings GT, Sullivan EV: Working memory
and strategic memory deficits in schizophrenia.  Neuropsychol-
ogy 1998, 12:278-288.
17. Chey J, Lee J, Kim YS, Kwon SM, Shin YM: Spatial working mem-
ory span, delayed response and executive function in schizo-
phrenia.  Psychiatry Res 2002, 110:259-271.
18. Gold JM, Bish JA, Viannone VN, Hobart MP, Queern CA, Buchanan
RW: Effects of contextual processing on visual conditional
associative learning in schizophrenia.  Biol Psychiatry 2000,
48:406-414.
19. Kemali D, Maj M, Galderisi S, Monteleone P, Mucci A: Conditional
associative learning in drug-free schizophrenic patients.  Neu-
ropsychobiology 1987, 17:30-34.
20. Rushe TM, Woodruff PWR, Murray RM, Morris RG: Episodic mem-
ory and learning in patients with chronic schizophrenia.
Schizophr Res 1999, 35:85-96.
21. American Psychiatric Association: Diagnostic and Statistical
Manual of Mental Disorders.  4th edition. Washington, DC:
American Psychiatric Association; 2000. 
22. Kay SR, Opler LA, Fiszbein A: The positive and negative syn-
drome scale (PANSS) for schizophrenia.  Schizophr Bull 1987,
13:261-276.
23. Folstein MF, Folstein SE, McHugh PR: "Mini Mental State". A
practical method for grading the cognitive state of patients
for the clinician.  J Psychiatr Res 1975, 12:189-198.
24. Wechsler D: WAIS-R Manual. Wechsler Adult Intelligence
Scale Revised.  New York: The Psychological Corporation; 1981. 
25. First MB, Spitzer RL, Gibbon M, Williams JBW: Structural clinical
interview for DSM-IV Axis I disorders, clinician version
(SCID-CV).  Washington, DC, American Psychiatric Press, Inc;
1996. 
26. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simson
SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic
interview for genetic studies. Rationale, unique features, and
training.  In Arch Gen Psychiatry Volume 5. NIMH Genetics Initiative;
1994:849-859. 
27. R Development Core Team: R: A Language and Environment
for Statistical Computing.  Vienna, Austria: R Foundation for Sta-
tistical Computing; 2005. 
28. Frith CD, Done DJ: Towards a neuropsychology of schizophre-
nia.  Br J Psychiatry 1989, 153:437-443.
29. Frith CD, Friston KJ, Liddle PF, Frackowiak RS: PET imaging and
cognition in schizophrenia.  J R Soc Med 1992, 85:222-224.
30. Cohen JD, Servan-Schreiber D: Context, cortex and dopamine:
a connectionist approach to behavior and biology in schizo-
phrenia.  Psychol Rev 1992, 99:45-77.
31. Servan-Schreiber D, Cohen JD, Steingard S: Schizophrenia deficits
in the processing of context. A test of a theoretical model.
Arch Gen Psychiatry 1996, 53:1105-1112.
32. Braver TS, Barch DM, Cohen JD: Cognition and control in schiz-
ophrenia: A computational model of dopamine and prefron-
tal function.  Biol Psychiatry 1999, 46:312-328.
33. Cohen JD, Barch DM, Carter C, Servan-Schreiber D: Context-
processing deficits in schizophrenia: Converging evidence
from three theoretically motivated cognitive tasks.  J Abnorm
Psychol 1999, 108:120-133.
34. Frith CD, Friston KJ, Herold S, Silbersweig D, Fletcher P, Cahill C,
Dolan RJ, Frackowiak RS, Liddle PF: Regional brain activity in
chronic schizophrenia patients during performance of verbal
fluency task.  Br J Psychiatry 1995, 167:343-349.
35. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank
JA, Berman KF, Weinberger DR: Specific relationship between
prefrontal neuronal N-acetylaspartate and activation of the
working memory cortical network in schizophrenia.  Am J Psy-
chiatry 2000, 157:26-33.
36. Fuster JM: Synopsis of function and dysfunction of the frontal
lobe.  Acta Psychiatr Scand 1999:51-57.
37. Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Wein-
berger DR, Berman KF: Evidence for abnormal cortical func-
tional connectivity during working memory in
schizophrenia.  Am J Psychiatry 2001, 158:1809-1817.
38. Meyer-Lindenberg A, Olsen RK, Kohn PD, Brown T, Egan MF, Wein-
berger DR, Berman KF: Regionally specific disturbance of dor-
solateral prefrontal-hippocampal functional connectivity in
schizophrenia.  Arch Gen Psychiatry 2005, 62:379-386.
39. Pantelis C, Barnes TRE, Nelson HE, Tanner S, Weatherley L, Owen
AM, Robbins TW: Frontal-Striatal cognitive deficits in patients
with chronic schizophrenia.  Brain 1997, 120:1823-1843.
40. Peled A, Geva AB, Kremen WS, Blankfeld HM, Esfandiarfard R, Nor-
dahl TE: Functional connectivity and working memory in
schizophrenia: an EEG study.  Int J Neurosci 2001, 106:47-61.
41. Schlosser R, Gesierich T, Kaufmann B, Vucurevic G, Stoeter P:
Altered effective connectivity in drug-free schizophrenic
patients.  Neuroreport 2003, 14:2233-2237.
42. Schlosser R, Gesierich T, Kaufmann B, Vucurevic G, Hunsche S,
Gaewehn J, Stoeter P: Altered effective connectivity during
working memory performance in schizophrenia: a study
with fMRI and structural equation modeling.  Neuroimage 2003,
19:751-763.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-244X/8/6/prepub